Leif Lindholm

Title: Leif Lindholm: Innovator in Viral Therapeutics

Introduction

Leif Lindholm is a prominent inventor based in Göteborg, Sweden. He has made significant contributions to the field of viral therapeutics, holding a total of 2 patents. His work focuses on the modification of viruses for therapeutic applications, particularly in cancer treatment.

Latest Patents

Lindholm's latest patents include a modified virus comprising one or more non-native polypeptides. This invention discloses a modified virus that includes one or more non-native polypeptides and explores its use in therapy, especially for treating tumors or other cancerous cells. The polypeptides contain framework moieties with binding capabilities, allowing them to be expressed in the cytoplasm and nucleus of mammalian host cells. This conformation is maintained even in the absence of a ligand for the binding moieties, enabling subsequent binding when the ligand is present. Additionally, the polypeptide can transport through the nuclear membrane, and the modified virus exhibits an altered tropism due to the binding moieties. Another patent focuses on the targeted delivery of virus vectors to mammalian cells.

Career Highlights

Leif Lindholm is currently associated with Got-a-gene AB, where he continues to innovate in the field of gene therapy and viral applications. His work has the potential to revolutionize treatment methodologies for various cancers.

Collaborations

Lindholm collaborates with notable colleagues, including Anna Karin Nord and Pierre Alain Boulanger, contributing to a dynamic research environment.

Conclusion

Leif Lindholm's innovative work in viral therapeutics showcases his commitment to advancing medical science. His patents reflect a deep understanding of molecular biology and its applications in cancer treatment.